Liraglutide treatment reduced interleukin‐6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy

AIMS: Type 1 diabetes can be complicated with neuropathy that involves immune‐mediated and inflammatory pathways. Glucagon‐like peptide‐1 receptor agonists such as liraglutide, have shown anti‐inflammatory properties, and thus we hypothesized that long‐term treatment with liraglutide induced diminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Brock, Christina, Hansen, Christian Stevns, Karmisholt, Jesper, Møller, Holger Jon, Juhl, Anne, Farmer, Adam Donald, Drewes, Asbjørn Mohr, Riahi, Sam, Lervang, Hans Henrik, Jakobsen, Poul Erik, Brock, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848951/
https://www.ncbi.nlm.nih.gov/pubmed/31338868
http://dx.doi.org/10.1111/bcp.14063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848951/
https://www.ncbi.nlm.nih.gov/pubmed/31338868
http://dx.doi.org/10.1111/bcp.14063

Ejemplares similares